Intracranial Hematomas

Multiple traumatic hematomas (MG) account for 0.74% of all traumatic brain injuries. A comprehensive diagnostic approach to multiple traumatic intracranial hematomas allows to establish a diagnosis in the early stages of traumatic brain injury and to determine treatment tactics. A differentiated approach to the choice of surgical treatment of multiple hematomas allows to achieve satisfactory results and treatment outcomes, which accordingly contributes to the early activation of the patient, a reduction in hospital stay, a decrease in mortality and disabilityin patients with traumatic brain injury

Download Full-text

Assessing the Evolution of Intracranial Hematomas by using Animal Models: A Review of the Progress and the Challenges

Metabolic Brain Disease ◽

10.1007/s11011-021-00828-y ◽

2021 ◽

Author(s):

Yihao Chen ◽

Jianbo Chang ◽

Junji Wei ◽

Ming Feng ◽

Renzhi Wang

Keyword(s):

Animal Models ◽

Intracranial Hematomas

Download Full-text

ROLE OF DECOMPRESSIVE CRANIECTOMY IN PATIENTS WITH TRAUMATIC INTRACRANIAL HEMATOMAS.

10.36106/ijsr/5937880 ◽

2020 ◽

pp. 1-2

Author(s):

Amar Nath

Keyword(s):

Clinical Outcome ◽

Decompressive Craniectomy ◽

Negative Impact ◽

Secondary Injury ◽

Raised Intracranial Pressure ◽

Significant Extent ◽

Decompressive Craniotomy ◽

Intracranial Hematomas ◽

Second Procedure

Aim – The study done to evaluate the role of decompressive craniectomy in patients with traumatic intracranial hematomas. Introduction - Although decompressive craniectomy for traumatic brain injury is very effective procedure in patients with raised intracranial pressure refractory to medical measures, its effect on clinical outcome is still unclear because of both positive as well as negative impact of procedure. As after decompressive craniectomy, clinical outcome becomes mainly dependent on primary head injury as secondary injury is prevented by decompressive craniectomy and beneficial effect of decompressive craniectomy is partially neutralized by complications associated with it to a small but significant extent. Patients and method - we retrospectively analysed 72 patients operated in last five years for traumatic intracranial hematomas by decompressive craniotomy. We followed practice of large craniotomy and evacuation of hematomas in last five years in properly selected patients and reserving craniectomy as second procedure in patients in whom patient did not improve radiologically/clinically after craniotomy. Results - In 61 out of 72 patients operated by decompressive craniotomy, there has been significant improvement in GCS of patients and none of patients needed decompressive craniectomy.

Download Full-text

How to iGuide: flat panel detector, CT-assisted, minimally invasive evacuation of intracranial hematomas

Journal of NeuroInterventional Surgery ◽

10.1136/neurintsurg-2021-017903 ◽

2021 ◽

pp. neurintsurg-2021-017903

Author(s):

David Dornbos III ◽

Cathra Halabi ◽

Julie DiNitto ◽

Kerstin Mueller ◽

David Fiorella ◽

...

Keyword(s):

Minimally Invasive ◽

Needle Guidance ◽

Flat Panel ◽

Neurologic Recovery ◽

Flat Panel Detector ◽

Minimally Invasive Surgical ◽

Intracranial Hematomas ◽

Navigation Accuracy ◽

High Degree ◽

Minimally Invasive Methods

Evidence is growing to support minimally invasive surgical evacuation of intraparenchymal hematomas, particularly those with minimal residual hematoma volumes following evacuation. To maximize the potential for neurologic recovery, it is imperative that the trajectory for access to the hematoma minimizes disruption of normal parenchyma. Flat panel detector CT-based navigation and needle guidance software provides a platform that uses flat panel detector CT imaging obtained on the angiography table to aid reliable and safe access to the hematoma. In addition to providing a high degree of accuracy, this method also allows convenient and rapid re-imaging to assess navigation accuracy and the degree of hematoma evacuation prior to procedural completion. We provide a practical review of the syngo iGuide needle guidance software and the methodology for incorporating its use, and the software of other vendors, in a variety of minimally invasive methods for evacuation of intraparenchymal hematomas.

Download Full-text